Human Anti-CD40 Antagonist Antibody Triggers Significant Antitumor Activity against Human Multiple Myeloma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Human Anti-CD40 Antagonist Antibody Triggers Significant Antitumor Activity against Human Multiple Myeloma

Published:2005-07-01 Issue:13 Volume:65 Page:5898-5906
ISSN:0008-5472
Container-title:Cancer Research
language:en
Short-container-title:Cancer Res

Author:

Tai Yu-Tzu,Li Xianfeng,Tong Xia,Santos Daniel,Otsuki Takemi,Catley Laurence,Tournilhac Olivier,Podar Klaus,Hideshima Teru,Schlossman Robert,Richardson Paul,Munshi Nikhil C.,Luqman Mohammad,Anderson Kenneth C.

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 134 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of therapeutic monoclonal antibodies against DKK1 peptide-HLA-A2 complex to treat human cancers;Journal for ImmunoTherapy of Cancer;2024-01

2. Advances in the CD40-mediated Manipulation Strategies;Biosciences Biotechnology Research Asia;2023-03-30

3. FcγRs and Their Relevance for the Activity of Anti-CD40 Antibodies;International Journal of Molecular Sciences;2022-10-25

4. In ovo model in cancer research and tumor immunology;Frontiers in Immunology;2022-09-29

5. The Sec61 translocon is a therapeutic vulnerability in multiple myeloma;EMBO Molecular Medicine;2022-01-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP